Advertisement

Topics

Companies Related to "Needle-free Jet Injection of Reduced-dose, Intradermal, Influenza Vaccine in >= 6 to < 24-month-old Children" [Most Relevant Company Matches] RSS

14:44 EST 17th December 2018 | BioPortfolio

Here are the most relevant search results for "Needle-free Jet Injection of Reduced-dose, Intradermal, Influenza Vaccine in >= 6 to < 24-month-old Children" found in our extensive corporate database of over 50,000 company records.

Showing "Needle free Injection Reduced dose Intradermal Influenza Vaccine" Companies 1–25 of 1,800+

Extremely Relevant

FluGen

FluGen is an emerging leader in the fight to boost effectiveness of influenza vaccines and other infectious disease products. The company has differentiating technologies that enable it to create value and compete in the large, rapidly growing influenza vaccine market. FluGen is actively advancing a valuable product pipeline that provides the company with ...


ANTRANIK BENOHANIAN MD, FRCPC

Dr. Benohanian has been treating Hyperhidrosis since 1978. He has developed a new formulation of topical aluminum chloride in a salicylic acid gel which helped many people to avoid surgery.For those who do not respond to topical treatments, Dr. Benohanian is now using Botox to treat axillary, craniofacial and inguinal hyperhidrosis. With regard to hyperhidrosis of the hands and feet, many physicia...

PharmaJet, Inc.

PharmaJet, Inc. is a privately held company located in Denver, Colorado; San Francisco, California and Baltimore, Maryland. It develops, manufactures and markets vaccine and drug delivery products based on its proprietary needle-free jet injection technology.


PharmaJet Inc.

PharmaJet Inc., affiliated with Genesis Medical Technologies, is a needle-free drug delivery technology company. Through the use of its needle-free jet injection technology, the Company’s goal is to make a positive difference in improving global world health, helping to break the cycle of poverty and disease associated with needle-stick injury and needle re-use. With FDA 510 (k) clearance for t...

Seqirus

In an industry first, Seqirus has successfully produced cell-based influenza vaccine at commercial scale using a candidate vaccine virus (CVV) that has been isolated and grown in cells, rather than in eggs.1,2 CVVs are prepared by the World Health Organization (WHO) Global Influenza Surveillance and Response System (GISRS) and associated laboratories, and ...

FluGen, Inc.

FluGen, Inc. is a privately held biotechnology company founded in 2005 and based in Madison, WI. The company has been developing novel influenza vaccine technology first invented at the University of Wisconsin-Madison, in the laboratories of Dr. Yoshihiro Kawaoka and Dr. Gabriele Neumann, and exclusively licensed to FluGen by WARF. The REDEE FLU influenza ...

Vaxin Inc.

Vaxin Inc. is a clinical stage biotechnology company, founded in December 1997 with facilities in Rockville, MD and Birmingham, AL, developing next generation vaccines to address significant public health and biodefense needs. Vaxin is focused on vaccines designed to protect people against influenza and anthrax infection using proprietary, patented technol...

CSL Biotherapies

CSL Biotherapies has an initial contract worth $180 million to deliver bulk H1N1 vaccine antigen to the U.S. Health and Human Services Department (HHS), with an option for filling and packaging services out of CSL’s Kankakee, Illinois and Marburg, Germany facilities. These facilities have the capability to produce seasonal and pandemic influenza vacci...

Vaxxas

Vaxxas is a privately-held biotechnology company focused on enhancing the performance of existing and next generation vaccines with its proprietary Nanopatch™ technology platform. Vaxxas’ Nanopatch contains an ultra-high density array of projections – invisible to the naked human eye – that are dry-coated with vaccine. Application of the ...

Relevant

Sinovac Biotech Ltd.

Sinovac Biotech Ltd. is a China-based biopharmaceutical Company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases. Sinovac's product portfolio includes vaccines against enterovirus71, or EV71, hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H...

Glide Pharma

Glide Pharma is a specialty pharmaceutical company focused on the easy, safe and convenient administration of solid dose formulations of therapeutics and vaccines. The company has a range of in-house and partnered programmes based on its proprietary needle-free solid dose injector, the Glide SDI(R).

Variation Biotechnologies, Inc.

VBI is an emerging leader in the innovative formulation, delivery and development of vaccines. The Company’s powerful, proprietary technology platforms enable thermostable IM and thermostable oral vaccine delivery, creating improved dose equivalent and the potential for dose sparing and adjuvanted vaccines, extending vaccine reach and coverage in established...

Vaccine and Infectious Disease Organization

VIDO is a world leader in the research and development of vaccine and immunotherapeutic technologies for livestock and humans. It is credited with five "world firsts" in animal vaccine research, and is expanding into human health applications. Current research interests include vaccines against a number of food-borne organisms, and novel vaccine delivery systems including needle-free methods. VIDO...

Iomai

Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called transcutaneous immunization (TCI). TCI taps into the unique benefits of a major group of antigen-presenting cells found in the outer layers of the skin to generate an enhanced immune response. Iomai is leveraging TCI to enhance the efficacy of existing vaccines, en...

Zogenix, Inc.

Zogenix, Inc., with offices in Emeryville and San Diego, Calif., is a privately held pharmaceutical company focused on the development and commercialization of medicines to treat neuroscience disorders and pain. The company is commercially focused on SUMAVEL(TM) DosePro(TM) (sumatriptan injection) needle-free delivery system, which launched in January 2010, for the acute treatment of migraine and ...

Glide Pharmaceutical Technologies Ltd

Based near Oxford, UK, Glide Pharma is developing a pipeline of Glide-branded, “supergeneric” products and is also co-developing products with a growing list of pharmaceutical and biotech partners, all based on its proprietary Glide technology. Glide SDI allows the injection of drugs, vaccines and other active pharmaceutical ingredients in a solid form. Glide SDI is an innovative new needle-fr...

Bioject Medical Technologies

Bioject Medical Technologies Inc. (NASDAQ: BJCT) is an emerging drug delivery company developing the world's leading technology for needle-free injection of liquid medications.Bioject's technology works by forcing liquid medication at high speed through a tiny orifice held against the skin. This creates an ultra-fine stream of fluid that penetrates the skin, delivering medication in a fraction of ...

Sinovac Biotech, Ltd.

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's vaccine products include Healive(R) (hepatitis A), Bilive(R) (combined hepatitis A and B), and Anflu(R) (influenza). Panflu(TM), Sinovac's pandemic influenza vaccine (H5N1), has already...

NexBio Incorporated

In recent years the world has witnessed the outbreak of SARS, the worldwide spread of avian influenza viruses, and the escalating outbreaks of avian influenza viruses in humans. The present unavailability of a vaccine against avian influenza infection in humans is of grave concern. Health authorities worldwide fear an imminent and inevitable influenza pandemic in addition to the more routine but ...

Generex Biotechnology

Generex Biotechnology Corporation is developing new methods for the delivery of large-molecule drugs. Our proprietary RapidMist TM device administers medications directly into the mouth as a metered-dose spray, for rapid absorption by the buccal mucosa. The potential benefits are compelling. Pain-free, needle-free, noninvasive drug delivery. Dosages administered accurately and conveniently. Improv...

Inviragen, Inc. and PharmaJet, Inc.

Inviragen is focused on developing vaccines to protect against infectious diseases worldwide. Inviragen's lead product candidate is a vaccine to protect against dengue fever. Inviragen is also developing vaccines to protect against hand, foot and mouth disease and Japanese encephalitis, both of which affect millions of children in Asia. Vaccines in preclin...

PaxVax Inc.

PaxVax is a privately held specialty vaccine company founded in 2007. PaxVax is focused on traveler vaccines with an emerging pipeline in biodefense coupled with a social mission to ensure global access to its vaccines. PaxVax’s clinical-stage product portfolio includes an oral, single-dose cholera vaccine in Phase 3 clinical trials, a pandemic H5N1 i...

Novavax

Novavax Inc. is a biotechnology company committed to leading the global fight against infectious diseases by creating novel, highly potent vaccines that are safer and more effective than current preventive options. Our world-class scientific team is using virus-like particle (VLP) technology to tackle influenza viruses – including avian strains that have the potential to cause a pandemic outbrea...

Sinovac Biotech Ltd.

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's vaccine products include Healive(R) (hepatitis A), Bilive(R) (combined hepatitis A and B), and Anflu(R) (influenza). PanfluTM, Sinovac's pandemic influenza vaccine (H5N1), has already b...

Inviragen, Inc. and Duke-NUS

Inviragen is focused on developing vaccines to protect against infectious diseases worldwide. Inviragen's lead product candidate is a vaccine to protect against dengue fever. Inviragen is also developing vaccines to protect against hand, foot and mouth disease, chikungunya and Japanese encephalitis which affect millions of individuals in Asia. Vaccines in ...


More From BioPortfolio on "Needle-free Jet Injection of Reduced-dose, Intradermal, Influenza Vaccine in >= 6 to < 24-month-old Children"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks